Sales and earnings (Q2 2023)
- Net revenue
- 572,1 MSEK (+21%)
- Op. EBITDA
- 119,5 MSEK (-3%)
Financial reports
Calendar
- September 14
- Pareto Healthcare Seminar - Stockholm, Sweden
- September 28
- Jefferies Annual Pet Care & Wellness conference (London)
- January 8 2024
- SEB Nordic Seminar (Copenhagen)
- February 15 2024
- Yearend report 2023
Pressreleases & news
- Swedencare AB (publ) HALF YEAR REPORT April 1st – June 30th 2023
- 27 JULY 2023 08:00
- Invitation to Swedencare AB (publ) 2023 half year report presentation
- 20 JULY 2023 09:00
- Statement by the Board of Directors of Swedencare AB (publ) in relation to the mandatory bid offer from Symrise AG Regulatory
- 30 JUNE 2023 08:30
- Group Management addition
- 22 JUNE 2023 14:40
- Symrise has published a mandatory tender offer to the shareholders of Swedencare
- 7 JUNE 2023 09:00
- Swedencare AB (publ) INTERIM REPORT January 1st – March 31st 2023
- 28 APRIL 2023 08:00
- Notice of Annual general meeting in Swedencare AB (publ)
- 28 MARCH 2023 1.00
Latest presentations
- Swedencare Q2 2023 Webinar (video & presentation)
- JULY 27 2023
- Swedencare Q1 2023 Webinar (video & presentation)
- APRIL 28 2023
- Swedencare Q4 2022 Webinar (video & presentation)
- FEBRUARY 16 2023
- Swedencare Q3 2022 Webinar (video & presentation)
- OCTOBER 27 2022
- Swedencare Q2 2022 Webinar (video & presentation)
- JULY 28 2022
Sign up for news
Stay up-to-date with the latest news!
Presentation of Q2 2023
”The second quarter’s net revenue of 572.1 MSEK represents a 21% increase compared to Q2 2022, marking our strongest quarter ever. At the same time, our operational EBITDA is 119.5 MSEK, corresponding to a margin of 20.9%. Our strong cash flow during the quarter enabled a total of 105 MSEK in paid dividends, payment for an acquisition, and amortizations.” – Håkan Lagerberg, CEO
You must accept marketing cookies to view this content.